Pathstone Family Office’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-33
Closed 777
2020
Q4
$0 Hold
33
﹤0.01% 1174
2020
Q3
$0 Sell
33
-33
-50% -$209 ﹤0.01% 816
2020
Q2
$0 Buy
+66
New +$405 ﹤0.01% 747
2018
Q2
Sell
-200
Closed -$2K 187
2018
Q1
$2K Hold
200
﹤0.01% 315
2017
Q4
$3K Hold
200
﹤0.01% 118
2017
Q3
$3K Hold
200
﹤0.01% 158
2017
Q2
$3K Hold
200
﹤0.01% 346
2017
Q1
$3K Buy
+200
New +$2.94K ﹤0.01% 344
2016
Q4
Sell
-200
Closed -$2K 115
2016
Q3
$2K Hold
200
﹤0.01% 185
2016
Q2
$3K Hold
200
﹤0.01% 186
2016
Q1
$2K Hold
200
﹤0.01% 161
2015
Q4
$3K Hold
200
0.01% 76
2015
Q3
$3K Hold
200
0.01% 144
2015
Q2
$3K Hold
200
0.01% 114
2015
Q1
$2K Hold
200
﹤0.01% 116
2014
Q4
$2K Hold
200
0.01% 102
2014
Q3
$2K Hold
200
0.01% 288
2014
Q2
$1K Hold
200
﹤0.01% 130
2014
Q1
$2K Hold
200
0.01% 151
2013
Q4
$2K Hold
200
﹤0.01% 190
2013
Q3
$1K Hold
200
﹤0.01% 291
2013
Q2
$1K Buy
+200
New +$1.02K ﹤0.01% 351

Other funds holding CCRN

Pathstone Family Office's CCRN Position: Q1 2021 in Review

Pathstone Family Office sold out of Cross Country Healthcare (CCRN) in Q1 2021, closing a stake of 33 shares.

Pathstone Family Office first reported a position in CCRN in Q2 2013 and held it in 22 quarters. The position peaked at $3K in Q4 2017. 129 funds tracked by Wall St. Rank hold CCRN as of Q1 2021.

  • Pathstone Family Office reported no remaining Cross Country Healthcare position as of Q1 2021 after selling out during the quarter.
  • Pathstone Family Office sold 33 Cross Country Healthcare shares in Q1 2021.
  • Pathstone Family Office first reported a position in Cross Country Healthcare in Q2 2013 and held it in 22 quarters.
  • Pathstone Family Office's Cross Country Healthcare position peaked at $3K in Q4 2017.
  • 129 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2021.

Based on Pathstone Family Office's 13F filing for Q1 2021, filed 14 May 2021.